Medtronic (MDT)
NYSE: MDT
· Real-Time Price · USD
82.97
0.56 (0.68%)
At close: May 30, 2025, 3:59 PM
83.15
0.21%
After-hours: May 30, 2025, 05:57 PM EDT
Medtronic Revenue Breakdown
Period Ending | Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 24, 2020 | Apr 26, 2019 | Apr 27, 2018 | Apr 28, 2017 | Apr 29, 2016 | Apr 24, 2015 |
---|---|---|---|---|---|---|---|---|---|
Cardiac and Vascular Group Revenue | 11.83B | 11.57B | 11.42B | 10.47B | 11.51B | 11.35B | 10.5B | 10.2B | 9.36B |
Cardiac and Vascular Group Revenue Growth | +2.23% | +1.31% | +9.12% | -9.01% | +1.33% | +8.15% | +2.96% | +8.92% | n/a |
Diabetes Group Revenue | 2.49B | 2.26B | 2.34B | 2.37B | 2.39B | 2.14B | 1.93B | 1.86B | 1.76B |
Diabetes Group Revenue Growth | +9.99% | -3.25% | -1.27% | -0.96% | +11.73% | +11.05% | +3.38% | +5.79% | n/a |
Medical Surgical Revenue | 8.42B | 8.43B | 9.14B | n/a | n/a | n/a | n/a | n/a | n/a |
Medical Surgical Revenue Growth | -0.19% | -7.75% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Neuroscience Group Revenue | 9.41B | 8.96B | 8.78B | n/a | n/a | n/a | n/a | n/a | n/a |
Neuroscience Group Revenue Growth | +4.99% | +1.99% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Period Ending | Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 |
---|---|---|---|---|---|---|
Japan, Australia, New Zealand, Korea, Canada, And Western Europe Revenue | 9.98B | 9.41B | 10.13B | 9.81B | 9.29B | 9.63B |
Japan, Australia, New Zealand, Korea, Canada, And Western Europe Revenue Growth | +6.07% | -7.09% | +3.17% | +5.69% | -3.57% | n/a |
Middle East, Africa, Latin America, Eastern Europe, And Asia, Excluding Japan And Korea Revenue | 5.82B | 5.45B | 5.43B | 4.78B | 4.71B | 4.73B |
Middle East, Africa, Latin America, Eastern Europe, And Asia, Excluding Japan And Korea Revenue Growth | +6.92% | +0.37% | +13.59% | +1.49% | -0.53% | n/a |
Operating Expense Breakdown
Period Ending | Jan 24, 2025 | Oct 25, 2024 | Jul 26, 2024 | Apr 26, 2024 | Jan 26, 2024 | Oct 27, 2023 | Jul 28, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Apr 30, 2021 | Jan 29, 2021 | Oct 30, 2020 | Jul 31, 2020 | Apr 24, 2020 | Jan 24, 2020 | Oct 25, 2019 | Jul 26, 2019 | Apr 26, 2019 | Jan 25, 2019 | Oct 26, 2018 | Jul 27, 2018 | Apr 27, 2018 | Jan 26, 2018 | Oct 27, 2017 | Jul 28, 2017 | Apr 28, 2017 | Jan 27, 2017 | Oct 28, 2016 | Jul 29, 2016 | Apr 29, 2016 | Jan 29, 2016 | Oct 30, 2015 | Jul 31, 2015 | Apr 24, 2015 | Jan 23, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 2.72B | 2.76B | 2.63B | 2.73B | 2.67B | 2.69B | 2.61B | 2.62B | 2.62B | 2.62B | 2.54B | 2.52B | 2.56B | 2.62B | 2.55B | 2.59B | 2.54B | 2.6B | 2.42B | 2.36B | 2.59B | 2.62B | 2.54B | 2.62B | 2.6B | 2.6B | 2.6B | 2.55B | 2.5B | 2.44B | 2.48B | 2.48B | 2.39B | 2.42B | 2.43B | 2.36B | 2.32B | 2.34B | 2.45B | 2.4B | 1.49B |
Selling, General, and Administrative Revenue Growth | -1.45% | +4.99% | -3.84% | +2.17% | -0.48% | +2.79% | -0.11% | +0.04% | -0.08% | +3.07% | +0.55% | -1.41% | -2.07% | +2.67% | -1.81% | +2.25% | -2.42% | +7.57% | +2.42% | -8.77% | -1.26% | +3.03% | -2.94% | +0.92% | -0.35% | +0.31% | +1.76% | +2.12% | +2.50% | -1.89% | +0.24% | +3.81% | -1.16% | -0.49% | +2.88% | +1.86% | -1.11% | -4.33% | +1.87% | +61.67% | n/a |
Research and Development Revenue | 675M | 697M | 676M | 675M | 695M | 698M | 668M | 641M | 688M | 676M | 692M | 652M | 668M | 676M | 750M | 632M | 601M | 639M | 621M | 567M | 573M | 603M | 587M | 594M | 561M | 590M | 585M | 592M | 558M | 555M | 548M | 553M | 530M | 554M | 556M | 575M | 546M | 545M | 558M | 528M | 373M |
Research and Development Revenue Growth | -3.16% | +3.11% | +0.15% | -2.88% | -0.43% | +4.49% | +4.21% | -6.83% | +1.78% | -2.31% | +6.13% | -2.40% | -1.18% | -9.87% | +18.67% | +5.16% | -5.95% | +2.90% | +9.52% | -1.05% | -4.98% | +2.73% | -1.18% | +5.88% | -4.92% | +0.85% | -1.18% | +6.09% | +0.54% | +1.28% | -0.90% | +4.34% | -4.33% | -0.36% | -3.30% | +5.31% | +0.18% | -2.33% | +5.68% | +41.55% | n/a |